Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients

Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I

(2010) Shunji Tomatsu et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Guidelines for the Management of Mucopolysaccharidosis Type I

(2009) Ana Maria Martins et al.   JOURNAL OF PEDIATRICS

Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II

(2009) Raymond Y. Wang et al.   MOLECULAR GENETICS AND METABOLISM

Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry

(2009) Shunji Tomatsu et al.   MOLECULAR GENETICS AND METABOLISM

Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis

(2008) N. Volpi et al.   GLYCOBIOLOGY

Structural Analysis of Bikunin Glycosaminoglycan

(2008) Lianli Chi et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Heparin cofactor II–thrombin complex: A biomarker of MPS disease

(2008) Derrick R. Randall et al.   MOLECULAR GENETICS AND METABOLISM

Stability of urinary glycosaminoglycans in patients with mucopolysaccharidoses

(2007) Fernando Andrade et al.   CLINICA CHIMICA ACTA